$0.8371
0.02222.72%
In chiusura: Nov 21, 4:00 PM EST
$0.8073
-0.0298-3.56%
After hour: 6:56 PM EST
Galmed Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Galmed Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
GLMD | Galmed Pharmaceuticals | -$2.31 | -$0.54 | — | — | $0.00 | — | — | — | 12/05/2025 | |
GLMD | Galmed Pharmaceuticals | -$1.65 | -$0.79 | -$0.63 | 24.10% | $0.00 | — | $0.00 | — | 08/28/2025 | |
GLMD | Galmed Pharmaceuticals | -$2.10 | — | -$0.62 | — | $0.00 | — | $0.00 | — | 05/22/2025 | |
GLMD | Galmed Pharmaceuticals | -$11.76 | — | -$0.85 | — | $0.00 | — | $0.00 | — | 04/02/2025 | |
GLMD | Galmed Pharmaceuticals | -$3.43 | — | -$2.31 | — | $0.00 | — | $0.00 | — | 11/14/2024 | |
GLMD | Galmed Pharmaceuticals | -$11.40 | — | -$2.16 | — | $0.00 | — | $0.00 | — | 08/28/2024 | |
GLMD | Galmed Pharmaceuticals | -$13.08 | — | -$2.76 | — | $0.00 | — | $0.00 | — | 05/30/2024 | |
GLMD | Galmed Pharmaceuticals | -$18.00 | -$3.84 | -$11.76 | -206.25% | $0.00 | — | $0.00 | — | 04/04/2024 | |
GLMD | Galmed Pharmaceuticals | -$37.80 | -$3.60 | -$2.88 | 20.00% | $0.00 | — | $0.00 | — | 11/22/2023 | |
GLMD | Galmed Pharmaceuticals | -$27.00 | -$4.08 | -$11.40 | -179.41% | $0.00 | — | $0.00 | — | 08/09/2023 | |
GLMD | Galmed Pharmaceuticals | -$43.20 | -$18.00 | -$13.08 | 27.33% | $0.00 | — | $0.00 | — | 06/01/2023 | |
GLMD | Galmed Pharmaceuticals | -$54.00 | -$25.20 | -$18.00 | 28.57% | $0.00 | — | $0.00 | — | 03/29/2023 | |
GLMD | Galmed Pharmaceuticals | -$55.80 | -$28.80 | -$37.80 | -31.25% | $0.00 | — | $0.00 | — | 11/16/2022 | |
GLMD | Galmed Pharmaceuticals | -$59.40 | -$43.20 | -$27.00 | 37.50% | $0.00 | — | $0.00 | — | 08/04/2022 | |
GLMD | Galmed Pharmaceuticals | -$68.40 | -$57.60 | -$43.20 | 25.00% | $0.00 | — | $0.00 | — | 05/17/2022 | |
GLMD | Galmed Pharmaceuticals | -$86.40 | -$54.00 | -$54.00 | 0.00% | $0.00 | — | $0.00 | — | 05/02/2022 | |
GLMD | Galmed Pharmaceuticals | -$57.60 | -$64.80 | -$55.80 | 13.89% | $0.00 | — | $0.00 | — | 11/08/2021 | |
GLMD | Galmed Pharmaceuticals | -$46.80 | -$68.40 | -$59.40 | 13.16% | $0.00 | — | $0.00 | — | 08/05/2021 | |
GLMD | Galmed Pharmaceuticals | -$52.20 | -$70.20 | -$68.40 | 2.56% | $0.00 | — | $0.00 | — | 05/13/2021 | |
GLMD | Galmed Pharmaceuticals | -$70.20 | -$64.80 | -$86.40 | -33.33% | $0.00 | — | $0.00 | — | 03/18/2021 |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-28 | $-0.63 | $-0.79 | 24.1 % |
| Q4 | 2024-04-04 | $-11.76 | $-3.84 | -206.3 % |
| Q3 | 2023-11-22 | $-2.88 | $-3.60 | 20.0 % |
| Q2 | 2023-08-09 | $-11.40 | $-4.08 | -179.4 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
Si prevede che Galmed Pharmaceuticals (GLMD) fornisca risultati il dicembre 5, 2025. Gli ultimi risultati sono stati pubblicati il agosto 28, 2025 per il Q2.
L'EPS effettivo era $-0.63, che superato la stima di $-0.79.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.